CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $102.27 billion. The enterprise value is $162.68 billion.
| Market Cap | 102.27B |
| Enterprise Value | 162.68B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Oct 22, 2026 |
Share Statistics
CVS Health has 1.28 billion shares outstanding. The number of shares has increased by 1.66% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | +1.66% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 90.38% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 9.32 and the forward PE ratio is 9.58. CVS Health's PEG ratio is 0.81.
| PE Ratio | 9.32 |
| Forward PE | 9.58 |
| PS Ratio | 0.24 |
| Forward PS | 0.24 |
| PB Ratio | 1.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.57 |
| P/OCF Ratio | 5.47 |
| PEG Ratio | 0.81 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.47, with an EV/FCF ratio of 10.45.
| EV / Earnings | 14.74 |
| EV / Sales | 0.39 |
| EV / EBITDA | 8.47 |
| EV / EBIT | 11.07 |
| EV / FCF | 10.45 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.93.
| Current Ratio | 0.85 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | 3.39 |
| Debt / FCF | 4.84 |
| Interest Coverage | 4.79 |
Financial Efficiency
Return on equity (ROE) is 14.36% and return on invested capital (ROIC) is 9.46%.
| Return on Equity (ROE) | 14.36% |
| Return on Assets (ROA) | 3.58% |
| Return on Invested Capital (ROIC) | 9.46% |
| Return on Capital Employed (ROCE) | 8.91% |
| Weighted Average Cost of Capital (WACC) | 5.86% |
| Revenue Per Employee | $1.39M |
| Profits Per Employee | $36,790 |
| Employee Count | 300,000 |
| Asset Turnover | 1.63 |
| Inventory Turnover | 19.40 |
Taxes
In the past 12 months, CVS Health has paid $1.07 billion in taxes.
| Income Tax | 1.07B |
| Effective Tax Rate | 8.85% |
Stock Price Statistics
The stock price has increased by +1.94% in the last 52 weeks. The beta is 0.58, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +1.94% |
| 50-Day Moving Average | 90.82 |
| 200-Day Moving Average | 88.89 |
| Relative Strength Index (RSI) | 30.27 |
| Average Volume (20 Days) | 9,968,968 |
Short Selling Information
The latest short interest is 16.19 million, so 1.27% of the outstanding shares have been sold short.
| Short Interest | 16.19M |
| Short Previous Month | 16.12M |
| Short % of Shares Out | 1.27% |
| Short % of Float | 1.27% |
| Short Ratio (days to cover) | 1.63 |
Income Statement
In the last 12 months, CVS Health had revenue of $418.38 billion and earned $11.04 billion in profits. Earnings per share was $8.58.
| Revenue | 418.38B |
| Gross Profit | 57.61B |
| Operating Income | 14.70B |
| Pretax Income | 12.12B |
| Net Income | 11.04B |
| EBITDA | 19.22B |
| EBIT | 14.70B |
| Earnings Per Share (EPS) | $8.58 |
Balance Sheet
The company has $14.89 billion in cash and $75.30 billion in debt, with a net cash position of -$60.41 billion or -$47.23 per share.
| Cash & Cash Equivalents | 14.89B |
| Total Debt | 75.30B |
| Net Cash | -60.41B |
| Net Cash Per Share | -$47.23 |
| Equity (Book Value) | 80.69B |
| Book Value Per Share | 62.89 |
| Working Capital | -13.71B |
Cash Flow
In the last 12 months, operating cash flow was $18.71 billion and capital expenditures -$3.14 billion, giving a free cash flow of $15.57 billion.
| Operating Cash Flow | 18.71B |
| Capital Expenditures | -3.14B |
| Depreciation & Amortization | 4.52B |
| Net Borrowing | -5.32B |
| Free Cash Flow | 15.57B |
| FCF Per Share | $12.17 |
Margins
Gross margin is 13.77%, with operating and profit margins of 3.51% and 2.64%.
| Gross Margin | 13.77% |
| Operating Margin | 3.51% |
| Pretax Margin | 2.90% |
| Profit Margin | 2.64% |
| EBITDA Margin | 4.59% |
| EBIT Margin | 3.51% |
| FCF Margin | 3.72% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.33%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.00% |
| FCF Payout Ratio | 21.85% |
| Buyback Yield | -1.66% |
| Shareholder Yield | 1.67% |
| Earnings Yield | 10.73% |
| FCF Yield | 15.22% |
Analyst Forecast
The average price target for CVS Health is $115.52, which is 44.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $115.52 |
| Price Target Difference | 44.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 3.91% |
| EPS Growth Forecast (3Y) | 12.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |